Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
22
2022
Delaware District Court Determines that HRSA Enforcement Letter Targeting 340B Program Restrictions Violates the APA Robinson & Cole LLP
Feb
22
2022
USDA Request to Affirm Hydroponics Organic Labeling Keller and Heckman LLP
Feb
22
2022
“Made With Milk Chocolate” Claims Dismissed Keller and Heckman LLP
Feb
21
2022
The Era of Digitization: The Mexican Sanitary Agency, COFEPRIS. OLIVARES
Feb
18
2022
McDermottPlus Check-Up: February 18, 2022 McDermott Will & Emery
Feb
18
2022
When in Rome, Try the Pizza! Norris McLaughlin P.A.
Feb
17
2022
D. Del. Says ANDA Specification Trumps All Else in Infringement Analysis Mintz
Feb
17
2022
Agriculture Groups Sue FDA on Chlorpyrifos Ban Keller and Heckman LLP
Feb
17
2022
Food & Chemicals Unpacked Podcast Ep. 1: PFAS and Furious [PODCAST] Keller and Heckman LLP
Feb
17
2022
Ruling Permits On-Premises Beer and Wine Licenses for New York Movie Theaters McDermott Will & Emery
Feb
17
2022
Federal Criminal Drug Counterfeiting Defense Oberheiden P.C.
Feb
17
2022
FDA Boosts Protein Preemption Defense Sheppard, Mullin, Richter & Hampton LLP
Feb
17
2022
Registration Opens for NanoEHS Webinar on “What We Know about NanoEHS: Building International Bridges” Bergeson & Campbell, P.C.
Feb
16
2022
Employers Take Heed: Follow Illinois Biometric Privacy Rules or Risk a Losing Battle Epstein Becker & Green, P.C.
Feb
16
2022
Restructure This! Episode 3: Canada: Cannabis Boom or Bust? [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Feb
16
2022
EPA Submits Final Rule on PIP (3:1) Compliance Date Extension to OMB Bergeson & Campbell, P.C.
Feb
16
2022
Recent Federal Developments: February 2022 Bergeson & Campbell, P.C.
Feb
16
2022
Dr. Califf Confirmed as New FDA Commissioner Keller and Heckman LLP
Feb
15
2022
EC Notifies WTO of Draft Amendment to Cosmetics Regulation to Prohibit Certain Nanomaterials Bergeson & Campbell, P.C.
Feb
15
2022
Treasury Responds to Biden Administration Executive Order With Report, Recommendations to Increase Alcohol Industry Competition [VIDEO] McDermott Will & Emery
Feb
15
2022
Episode 19: Health Care Industry Trends and Lessons Learned from the Commonwealth [PODCAST] Foley & Lardner LLP
Feb
15
2022
EPA Reopens Comment Period for Draft Revision to Risk Determination for HBCD Bergeson & Campbell, P.C.
Feb
15
2022
The Joint Commission Announces COVID Vaccine Surveys Have Begun Robinson & Cole LLP
Feb
15
2022
Slack Fill Class-Action Dismissed Keller and Heckman LLP
Feb
15
2022
The Joint Commission Announces COVID-19 Vaccine Surveys Have Begun Robinson & Cole LLP
Feb
14
2022
Pre-Employment Cannabis Testing: Is It Still Worth It? Foley & Lardner LLP
Feb
14
2022
Philadelphia and Montana Join List of Jurisdictions That Provide Protections for Recreational Marijuana Use Hunton Andrews Kurth
Feb
14
2022
California COVID Supplemental Sick Leave is Back Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins